APO Research
Talk to an analyst

APO RESEARCH · REPORT

Contraceptive Drug Eluting Devices

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Contraceptive Drug Eluting Devices Market Analysis and Forecast 2026-2032

28 December 2025203 pages

Choose your research edition.

Industry ResearchContraceptive Drug Eluting Devices Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Contraceptive Drug Eluting Devices Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Contraceptive Drug Eluting Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contraceptive Drug Eluting Devices Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Contraceptive Drug Eluting Devices Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Contraceptive Drug Eluting Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Contraceptive Drug Eluting Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Contraceptive Drug Eluting Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Contraceptive Drug Eluting Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Contraceptive Drug Eluting Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Contraceptive Drug Eluting Devices include CooperSurgical, Egemen International, ERENLER MEDIKAL, Gyneas, Laboratoire CCD, Medical Engineering Corporation, Melbea, Meril Life Sciences and Mona Lisa, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Contraceptive Drug Eluting Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Contraceptive Drug Eluting Devices, also provides the sales of main regions and countries. Of the upcoming market potential for Contraceptive Drug Eluting Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Contraceptive Drug Eluting Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Contraceptive Drug Eluting Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Contraceptive Drug Eluting Devices sales, projected growth trends, production technology, application and end-user industry.

Contraceptive Drug Eluting Devices Segment by Company

CooperSurgical

Egemen International

ERENLER MEDIKAL

Gyneas

Laboratoire CCD

Medical Engineering Corporation

Melbea

Meril Life Sciences

Mona Lisa

Pregna

Pregna International

Prosan International

Rongbo Medical

SMB Corporation of India

AbbVie

Bayer

Contraceptive Drug Eluting Devices Segment by Type

Non-biodegradable

Biodegradable

Contraceptive Drug Eluting Devices Segment by Application

Subcutaneously

Uterus

Contraceptive Drug Eluting Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptive Drug Eluting Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contraceptive Drug Eluting Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptive Drug Eluting Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Contraceptive Drug Eluting Devices in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Contraceptive Drug Eluting Devices manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Contraceptive Drug Eluting Devices sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Contraceptive Drug Eluting Devices Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Non-biodegradable Major Manufacturers Table 3. Biodegradable Major Manufacturers Table 4. Global Contraceptive Drug Eluting Devices Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Subcutaneously Major Manufacturers Table 6. Uterus Major Manufacturers Table 7. Contraceptive Drug Eluting Devices Industry Trends Table 8. Contraceptive Drug Eluting Devices Industry Drivers Table 9. Contraceptive Drug Eluting Devices Industry Opportunities and Challenges Table 10. Contraceptive Drug Eluting Devices Industry Restraints Table 11. Global Contraceptive Drug Eluting Devices Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Contraceptive Drug Eluting Devices Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Contraceptive Drug Eluting Devices Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Contraceptive Drug Eluting Devices Revenue Market Share by Region (2021-2026) Table 15. Global Contraceptive Drug Eluting Devices Revenue Market Share by Region (2027-2032) Table 16. Global Contraceptive Drug Eluting Devices Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Contraceptive Drug Eluting Devices Sales by Region (2021-2026) & (K Units) Table 18. Global Contraceptive Drug Eluting Devices Sales by Region (2027-2032) & (K Units) Table 19. Global Contraceptive Drug Eluting Devices Sales Market Share by Region (2021-2026) Table 20. Global Contraceptive Drug Eluting Devices Sales Market Share by Region (2027-2032) Table 21. Global Contraceptive Drug Eluting Devices Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Contraceptive Drug Eluting Devices Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Contraceptive Drug Eluting Devices Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Contraceptive Drug Eluting Devices Sales Market Share by Manufacturers (2021-2026) Table 25. Global Contraceptive Drug Eluting Devices Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Contraceptive Drug Eluting Devices Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Contraceptive Drug Eluting Devices Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Contraceptive Drug Eluting Devices Manufacturers, Product Type & Application Table 29. Global Contraceptive Drug Eluting Devices Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Contraceptive Drug Eluting Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Contraceptive Drug Eluting Devices Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Contraceptive Drug Eluting Devices Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Contraceptive Drug Eluting Devices Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Contraceptive Drug Eluting Devices Revenue Market Share by Type (2021-2026) Table 36. Global Contraceptive Drug Eluting Devices Revenue Market Share by Type (2027-2032) Table 37. Global Contraceptive Drug Eluting Devices Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Contraceptive Drug Eluting Devices Sales by Type (2021-2026) & (K Units) Table 39. Global Contraceptive Drug Eluting Devices Sales by Type (2027-2032) & (K Units) Table 40. Global Contraceptive Drug Eluting Devices Sales Market Share by Type (2021-2026) Table 41. Global Contraceptive Drug Eluting Devices Sales Market Share by Type (2027-2032) Table 42. Global Contraceptive Drug Eluting Devices Price by Type (2021-2026) & (US$/Unit) Table 43. Global Contraceptive Drug Eluting Devices Price by Type (2027-2032) & (US$/Unit) Table 44. Global Contraceptive Drug Eluting Devices Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Contraceptive Drug Eluting Devices Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Contraceptive Drug Eluting Devices Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Contraceptive Drug Eluting Devices Revenue Market Share by Application (2021-2026) Table 48. Global Contraceptive Drug Eluting Devices Revenue Market Share by Application (2027-2032) Table 49. Global Contraceptive Drug Eluting Devices Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Contraceptive Drug Eluting Devices Sales by Application (2021-2026) & (K Units) Table 51. Global Contraceptive Drug Eluting Devices Sales by Application (2027-2032) & (K Units) Table 52. Global Contraceptive Drug Eluting Devices Sales Market Share by Application (2021-2026) Table 53. Global Contraceptive Drug Eluting Devices Sales Market Share by Application (2027-2032) Table 54. Global Contraceptive Drug Eluting Devices Price by Application (2021-2026) & (US$/Unit) Table 55. Global Contraceptive Drug Eluting Devices Price by Application (2027-2032) & (US$/Unit) Table 56. CooperSurgical Company Information Table 57. CooperSurgical Business Overview Table 58. CooperSurgical Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. CooperSurgical Contraceptive Drug Eluting Devices Product Portfolio Table 60. CooperSurgical Recent Development Table 61. Egemen International Company Information Table 62. Egemen International Business Overview Table 63. Egemen International Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Egemen International Contraceptive Drug Eluting Devices Product Portfolio Table 65. Egemen International Recent Development Table 66. ERENLER MEDIKAL Company Information Table 67. ERENLER MEDIKAL Business Overview Table 68. ERENLER MEDIKAL Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. ERENLER MEDIKAL Contraceptive Drug Eluting Devices Product Portfolio Table 70. ERENLER MEDIKAL Recent Development Table 71. Gyneas Company Information Table 72. Gyneas Business Overview Table 73. Gyneas Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Gyneas Contraceptive Drug Eluting Devices Product Portfolio Table 75. Gyneas Recent Development Table 76. Laboratoire CCD Company Information Table 77. Laboratoire CCD Business Overview Table 78. Laboratoire CCD Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Laboratoire CCD Contraceptive Drug Eluting Devices Product Portfolio Table 80. Laboratoire CCD Recent Development Table 81. Medical Engineering Corporation Company Information Table 82. Medical Engineering Corporation Business Overview Table 83. Medical Engineering Corporation Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Medical Engineering Corporation Contraceptive Drug Eluting Devices Product Portfolio Table 85. Medical Engineering Corporation Recent Development Table 86. Melbea Company Information Table 87. Melbea Business Overview Table 88. Melbea Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Melbea Contraceptive Drug Eluting Devices Product Portfolio Table 90. Melbea Recent Development Table 91. Meril Life Sciences Company Information Table 92. Meril Life Sciences Business Overview Table 93. Meril Life Sciences Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Meril Life Sciences Contraceptive Drug Eluting Devices Product Portfolio Table 95. Meril Life Sciences Recent Development Table 96. Mona Lisa Company Information Table 97. Mona Lisa Business Overview Table 98. Mona Lisa Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Mona Lisa Contraceptive Drug Eluting Devices Product Portfolio Table 100. Mona Lisa Recent Development Table 101. Pregna Company Information Table 102. Pregna Business Overview Table 103. Pregna Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Pregna Contraceptive Drug Eluting Devices Product Portfolio Table 105. Pregna Recent Development Table 106. Pregna International Company Information Table 107. Pregna International Business Overview Table 108. Pregna International Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Pregna International Contraceptive Drug Eluting Devices Product Portfolio Table 110. Pregna International Recent Development Table 111. Prosan International Company Information Table 112. Prosan International Business Overview Table 113. Prosan International Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Prosan International Contraceptive Drug Eluting Devices Product Portfolio Table 115. Prosan International Recent Development Table 116. Rongbo Medical Company Information Table 117. Rongbo Medical Business Overview Table 118. Rongbo Medical Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Rongbo Medical Contraceptive Drug Eluting Devices Product Portfolio Table 120. Rongbo Medical Recent Development Table 121. SMB Corporation of India Company Information Table 122. SMB Corporation of India Business Overview Table 123. SMB Corporation of India Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. SMB Corporation of India Contraceptive Drug Eluting Devices Product Portfolio Table 125. SMB Corporation of India Recent Development Table 126. AbbVie Company Information Table 127. AbbVie Business Overview Table 128. AbbVie Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. AbbVie Contraceptive Drug Eluting Devices Product Portfolio Table 130. AbbVie Recent Development Table 131. Bayer Company Information Table 132. Bayer Business Overview Table 133. Bayer Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Bayer Contraceptive Drug Eluting Devices Product Portfolio Table 135. Bayer Recent Development Table 136. North America Contraceptive Drug Eluting Devices Revenue by Type (2021-2026) & (US$ Million) Table 137. North America Contraceptive Drug Eluting Devices Revenue by Type (2027-2032) & (US$ Million) Table 138. North America Contraceptive Drug Eluting Devices Sales by Type (2021-2026) & (K Units) Table 139. North America Contraceptive Drug Eluting Devices Sales by Type (2027-2032) & (K Units) Table 140. North America Contraceptive Drug Eluting Devices Sales Price by Type (2021-2026) & (US$/Unit) Table 141. North America Contraceptive Drug Eluting Devices Sales Price by Type (2027-2032) & (US$/Unit) Table 142. North America Contraceptive Drug Eluting Devices Revenue by Application (2021-2026) & (US$ Million) Table 143. North America Contraceptive Drug Eluting Devices Revenue by Application (2027-2032) & (US$ Million) Table 144. North America Contraceptive Drug Eluting Devices Sales by Application (2021-2026) & (K Units) Table 145. North America Contraceptive Drug Eluting Devices Sales by Application (2027-2032) & (K Units) Table 146. North America Contraceptive Drug Eluting Devices Sales Price by Application (2021-2026) & (US$/Unit) Table 147. North America Contraceptive Drug Eluting Devices Sales Price by Application (2027-2032) & (US$/Unit) Table 148. North America Contraceptive Drug Eluting Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. North America Contraceptive Drug Eluting Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 150. North America Contraceptive Drug Eluting Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 151. North America Contraceptive Drug Eluting Devices Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 152. North America Contraceptive Drug Eluting Devices Sales by Country (2021-2026) & (K Units) Table 153. North America Contraceptive Drug Eluting Devices Sales by Country (2027-2032) & (K Units) Table 154. North America Contraceptive Drug Eluting Devices Sales Price by Country (2021-2026) & (US$/Unit) Table 155. North America Contraceptive Drug Eluting Devices Sales Price by Country (2027-2032) & (US$/Unit) Table 156. United States Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 157. Canada Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 158. Mexico Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 159. Europe Contraceptive Drug Eluting Devices Revenue by Type (2021-2026) & (US$ Million) Table 160. Europe Contraceptive Drug Eluting Devices Revenue by Type (2027-2032) & (US$ Million) Table 161. Europe Contraceptive Drug Eluting Devices Sales by Type (2021-2026) & (K Units) Table 162. Europe Contraceptive Drug Eluting Devices Sales by Type (2027-2032) & (K Units) Table 163. Europe Contraceptive Drug Eluting Devices Sales Price by Type (2021-2026) & (US$/Unit) Table 164. Europe Contraceptive Drug Eluting Devices Sales Price by Type (2027-2032) & (US$/Unit) Table 165. Europe Contraceptive Drug Eluting Devices Revenue by Application (2021-2026) & (US$ Million) Table 166. Europe Contraceptive Drug Eluting Devices Revenue by Application (2027-2032) & (US$ Million) Table 167. Europe Contraceptive Drug Eluting Devices Sales by Application (2021-2026) & (K Units) Table 168. Europe Contraceptive Drug Eluting Devices Sales by Application (2027-2032) & (K Units) Table 169. Europe Contraceptive Drug Eluting Devices Sales Price by Application (2021-2026) & (US$/Unit) Table 170. Europe Contraceptive Drug Eluting Devices Sales Price by Application (2027-2032) & (US$/Unit) Table 171. Europe Contraceptive Drug Eluting Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. Europe Contraceptive Drug Eluting Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. Europe Contraceptive Drug Eluting Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. Europe Contraceptive Drug Eluting Devices Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 175. Europe Contraceptive Drug Eluting Devices Sales by Country (2021-2026) & (K Units) Table 176. Europe Contraceptive Drug Eluting Devices Sales by Country (2027-2032) & (K Units) Table 177. Europe Contraceptive Drug Eluting Devices Sales Price by Country (2021-2026) & (US$/Unit) Table 178. Europe Contraceptive Drug Eluting Devices Sales Price by Country (2027-2032) & (US$/Unit) Table 179. Germany Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 180. France Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 181. U.K. Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 182. Italy Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 183. Russia Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 184. Spain Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 185. Netherlands Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 186. Switzerland Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 187. Sweden Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 188. Poland Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 189. China Contraceptive Drug Eluting Devices Revenue by Type (2021-2026) & (US$ Million) Table 190. China Contraceptive Drug Eluting Devices Revenue by Type (2027-2032) & (US$ Million) Table 191. China Contraceptive Drug Eluting Devices Sales by Type (2021-2026) & (K Units) Table 192. China Contraceptive Drug Eluting Devices Sales by Type (2027-2032) & (K Units) Table 193. China Contraceptive Drug Eluting Devices Sales Price by Type (2021-2026) & (US$/Unit) Table 194. China Contraceptive Drug Eluting Devices Sales Price by Type (2027-2032) & (US$/Unit) Table 195. China Contraceptive Drug Eluting Devices Revenue by Application (2021-2026) & (US$ Million) Table 196. China Contraceptive Drug Eluting Devices Revenue by Application (2027-2032) & (US$ Million) Table 197. China Contraceptive Drug Eluting Devices Sales by Application (2021-2026) & (K Units) Table 198. China Contraceptive Drug Eluting Devices Sales by Application (2027-2032) & (K Units) Table 199. China Contraceptive Drug Eluting Devices Sales Price by Application (2021-2026) & (US$/Unit) Table 200. China Contraceptive Drug Eluting Devices Sales Price by Application (2027-2032) & (US$/Unit) Table 201. Asia Contraceptive Drug Eluting Devices Revenue by Type (2021-2026) & (US$ Million) Table 202. Asia Contraceptive Drug Eluting Devices Revenue by Type (2027-2032) & (US$ Million) Table 203. Asia Contraceptive Drug Eluting Devices Sales by Type (2021-2026) & (K Units) Table 204. Asia Contraceptive Drug Eluting Devices Sales by Type (2027-2032) & (K Units) Table 205. Asia Contraceptive Drug Eluting Devices Sales Price by Type (2021-2026) & (US$/Unit) Table 206. Asia Contraceptive Drug Eluting Devices Sales Price by Type (2027-2032) & (US$/Unit) Table 207. Asia Contraceptive Drug Eluting Devices Revenue by Application (2021-2026) & (US$ Million) Table 208. Asia Contraceptive Drug Eluting Devices Revenue by Application (2027-2032) & (US$ Million) Table 209. Asia Contraceptive Drug Eluting Devices Sales by Application (2021-2026) & (K Units) Table 210. Asia Contraceptive Drug Eluting Devices Sales by Application (2027-2032) & (K Units) Table 211. Asia Contraceptive Drug Eluting Devices Sales Price by Application (2021-2026) & (US$/Unit) Table 212. Asia Contraceptive Drug Eluting Devices Sales Price by Application (2027-2032) & (US$/Unit) Table 213. Asia Contraceptive Drug Eluting Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 214. Asia Contraceptive Drug Eluting Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 215. Asia Contraceptive Drug Eluting Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 216. Asia Contraceptive Drug Eluting Devices Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 217. Asia Contraceptive Drug Eluting Devices Sales by Country (2021-2026) & (K Units) Table 218. Asia Contraceptive Drug Eluting Devices Sales by Country (2027-2032) & (K Units) Table 219. Asia Contraceptive Drug Eluting Devices Sales Price by Country (2021-2026) & (US$/Unit) Table 220. Asia Contraceptive Drug Eluting Devices Sales Price by Country (2027-2032) & (US$/Unit) Table 221. Japan Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 222. South Korea Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 223. India Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 224. Australia Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 225. Taiwan Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 226. Southeast Asia Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 227. SAMEA Contraceptive Drug Eluting Devices Revenue by Type (2021-2026) & (US$ Million) Table 228. SAMEA Contraceptive Drug Eluting Devices Revenue by Type (2027-2032) & (US$ Million) Table 229. SAMEA Contraceptive Drug Eluting Devices Sales by Type (2021-2026) & (K Units) Table 230. SAMEA Contraceptive Drug Eluting Devices Sales by Type (2027-2032) & (K Units) Table 231. SAMEA Contraceptive Drug Eluting Devices Sales Price by Type (2021-2026) & (US$/Unit) Table 232. SAMEA Contraceptive Drug Eluting Devices Sales Price by Type (2027-2032) & (US$/Unit) Table 233. SAMEA Contraceptive Drug Eluting Devices Revenue by Application (2021-2026) & (US$ Million) Table 234. SAMEA Contraceptive Drug Eluting Devices Revenue by Application (2027-2032) & (US$ Million) Table 235. SAMEA Contraceptive Drug Eluting Devices Sales by Application (2021-2026) & (K Units) Table 236. SAMEA Contraceptive Drug Eluting Devices Sales by Application (2027-2032) & (K Units) Table 237. SAMEA Contraceptive Drug Eluting Devices Sales Price by Application (2021-2026) & (US$/Unit) Table 238. SAMEA Contraceptive Drug Eluting Devices Sales Price by Application (2027-2032) & (US$/Unit) Table 239. SAMEA Contraceptive Drug Eluting Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 240. SAMEA Contraceptive Drug Eluting Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 241. SAMEA Contraceptive Drug Eluting Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 242. SAMEA Contraceptive Drug Eluting Devices Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 243. SAMEA Contraceptive Drug Eluting Devices Sales by Country (2021-2026) & (K Units) Table 244. SAMEA Contraceptive Drug Eluting Devices Sales by Country (2027-2032) & (K Units) Table 245. SAMEA Contraceptive Drug Eluting Devices Sales Price by Country (2021-2026) & (US$/Unit) Table 246. SAMEA Contraceptive Drug Eluting Devices Sales Price by Country (2027-2032) & (US$/Unit) Table 247. Brazil Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 248. Argentina Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 249. Chile Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 250. Colombia Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 251. Peru Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 252. Saudi Arabia Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 253. Israel Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 254. UAE Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 255. Turkey Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 256. Iran Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 257. Egypt Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Table 258. Key Raw Materials Table 259. Raw Materials Key Suppliers Table 260. Contraceptive Drug Eluting Devices Distributors List Table 261. Contraceptive Drug Eluting Devices Customers List Table 262. Research Programs/Design for This Report Table 263. Authors List of This Report Table 264. Secondary Sources Table 265. Primary Sources List of Figures Figure 1. Contraceptive Drug Eluting Devices Image Figure 2. Global Contraceptive Drug Eluting Devices Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Contraceptive Drug Eluting Devices Market Size Share 2021 VS 2025 VS 2032 Figure 4. Non-biodegradable Image Figure 5. Biodegradable Image Figure 6. Global Contraceptive Drug Eluting Devices Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Contraceptive Drug Eluting Devices Market Size Share 2021 VS 2025 VS 2032 Figure 8. Subcutaneously Image Figure 9. Uterus Image Figure 10. Global Contraceptive Drug Eluting Devices Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Contraceptive Drug Eluting Devices Revenue (2021-2032) & (US$ Million) Figure 12. Global Contraceptive Drug Eluting Devices Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Contraceptive Drug Eluting Devices Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Contraceptive Drug Eluting Devices Revenue Market Share by Region (2021-2032) Figure 15. Global Contraceptive Drug Eluting Devices Sales (2021-2032) & (K Units) Figure 16. Global Contraceptive Drug Eluting Devices Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Contraceptive Drug Eluting Devices Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Contraceptive Drug Eluting Devices Sales YoY (2021-2032) & (K Units) Figure 19. Europe Contraceptive Drug Eluting Devices Sales YoY (2021-2032) & (K Units) Figure 20. China Contraceptive Drug Eluting Devices Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Contraceptive Drug Eluting Devices Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Contraceptive Drug Eluting Devices Sales YoY (2021-2032) & (K Units) Figure 23. Global Contraceptive Drug Eluting Devices Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Contraceptive Drug Eluting Devices Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Contraceptive Drug Eluting Devices Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Contraceptive Drug Eluting Devices Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Contraceptive Drug Eluting Devices Revenue Market Share by Type (2021-2032) Figure 29. Global Contraceptive Drug Eluting Devices Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Contraceptive Drug Eluting Devices Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Contraceptive Drug Eluting Devices Sales Market Share by Type (2021-2032) Figure 32. Global Contraceptive Drug Eluting Devices Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Contraceptive Drug Eluting Devices Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Contraceptive Drug Eluting Devices Revenue Market Share by Application (2021-2032) Figure 35. Global Contraceptive Drug Eluting Devices Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Contraceptive Drug Eluting Devices Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Contraceptive Drug Eluting Devices Sales Market Share by Application (2021-2032) Figure 38. North America Contraceptive Drug Eluting Devices Revenue Share by Type (2021-2032) Figure 39. North America Contraceptive Drug Eluting Devices Sales Share by Type (2021-2032) Figure 40. North America Contraceptive Drug Eluting Devices Revenue Share by Application (2021-2032) Figure 41. North America Contraceptive Drug Eluting Devices Sales Share by Application (2021-2032) Figure 42. North America Contraceptive Drug Eluting Devices Revenue Share by Country (2021-2032) Figure 43. North America Contraceptive Drug Eluting Devices Sales Share by Country (2021-2032) Figure 44. Europe Contraceptive Drug Eluting Devices Revenue Share by Type (2021-2032) Figure 45. Europe Contraceptive Drug Eluting Devices Sales Share by Type (2021-2032) Figure 46. Europe Contraceptive Drug Eluting Devices Revenue Share by Application (2021-2032) Figure 47. Europe Contraceptive Drug Eluting Devices Sales Share by Application (2021-2032) Figure 48. Europe Contraceptive Drug Eluting Devices Revenue Share by Country (2021-2032) Figure 49. Europe Contraceptive Drug Eluting Devices Sales Share by Country (2021-2032) Figure 50. China Contraceptive Drug Eluting Devices Revenue Share by Type (2021-2032) Figure 51. China Contraceptive Drug Eluting Devices Sales Share by Type (2021-2032) Figure 52. China Contraceptive Drug Eluting Devices Revenue Share by Application (2021-2032) Figure 53. China Contraceptive Drug Eluting Devices Sales Share by Application (2021-2032) Figure 54. Asia Contraceptive Drug Eluting Devices Revenue Share by Type (2021-2032) Figure 55. Asia Contraceptive Drug Eluting Devices Sales Share by Type (2021-2032) Figure 56. Asia Contraceptive Drug Eluting Devices Revenue Share by Application (2021-2032) Figure 57. Asia Contraceptive Drug Eluting Devices Sales Share by Application (2021-2032) Figure 58. Asia Contraceptive Drug Eluting Devices Revenue Share by Country (2021-2032) Figure 59. Asia Contraceptive Drug Eluting Devices Sales Share by Country (2021-2032) Figure 60. SAMEA Contraceptive Drug Eluting Devices Revenue Share by Type (2021-2032) Figure 61. SAMEA Contraceptive Drug Eluting Devices Sales Share by Type (2021-2032) Figure 62. SAMEA Contraceptive Drug Eluting Devices Revenue Share by Application (2021-2032) Figure 63. SAMEA Contraceptive Drug Eluting Devices Sales Share by Application (2021-2032) Figure 64. SAMEA Contraceptive Drug Eluting Devices Revenue Share by Country (2021-2032) Figure 65. SAMEA Contraceptive Drug Eluting Devices Sales Share by Country (2021-2032) Figure 66. Contraceptive Drug Eluting Devices Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Contraceptive Drug Eluting Devices Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Non-biodegradable
  • Biodegradable
Applications
  • Subcutaneously
  • Uterus
Companies covered
  • CooperSurgical
  • Egemen International
  • ERENLER MEDIKAL
  • Gyneas
  • Laboratoire CCD
  • Medical Engineering Corporation
  • Melbea
  • Meril Life Sciences
  • Mona Lisa
  • Pregna
  • Pregna International
  • Prosan International
  • Rongbo Medical
  • SMB Corporation of India
  • AbbVie
  • Bayer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Contraceptive Drug Eluting Devices Market by Type
  3. 1.2.1 Global Contraceptive Drug Eluting Devices Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Non-biodegradable
  5. 1.2.3 Biodegradable
  6. 1.3 Contraceptive Drug Eluting Devices Market by Application
  7. 1.3.1 Global Contraceptive Drug Eluting Devices Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Subcutaneously
  9. 1.3.3 Uterus
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Contraceptive Drug Eluting Devices Market Dynamics
  1. 2.1 Contraceptive Drug Eluting Devices Industry Trends
  2. 2.2 Contraceptive Drug Eluting Devices Industry Drivers
  3. 2.3 Contraceptive Drug Eluting Devices Industry Opportunities and Challenges
  4. 2.4 Contraceptive Drug Eluting Devices Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Contraceptive Drug Eluting Devices Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Contraceptive Drug Eluting Devices Revenue by Region
  3. 3.2.1 Global Contraceptive Drug Eluting Devices Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Contraceptive Drug Eluting Devices Revenue by Region (2021-2026)
  5. 3.2.3 Global Contraceptive Drug Eluting Devices Revenue by Region (2027-2032)
  6. 3.2.4 Global Contraceptive Drug Eluting Devices Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Contraceptive Drug Eluting Devices Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Contraceptive Drug Eluting Devices Sales by Region
  9. 3.4.1 Global Contraceptive Drug Eluting Devices Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Contraceptive Drug Eluting Devices Sales by Region (2021-2026)
  11. 3.4.3 Global Contraceptive Drug Eluting Devices Sales by Region (2027-2032)
  12. 3.4.4 Global Contraceptive Drug Eluting Devices Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Contraceptive Drug Eluting Devices Revenue by Manufacturers
  2. 4.1.1 Global Contraceptive Drug Eluting Devices Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Contraceptive Drug Eluting Devices Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Contraceptive Drug Eluting Devices Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Contraceptive Drug Eluting Devices Sales by Manufacturers
  6. 4.2.1 Global Contraceptive Drug Eluting Devices Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Contraceptive Drug Eluting Devices Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Contraceptive Drug Eluting Devices Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Contraceptive Drug Eluting Devices Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Contraceptive Drug Eluting Devices Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Contraceptive Drug Eluting Devices Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Contraceptive Drug Eluting Devices Manufacturers, Product Type & Application
  13. 4.7 Global Contraceptive Drug Eluting Devices Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Contraceptive Drug Eluting Devices Market CR5 and HHI
  16. 4.8.2 2025 Contraceptive Drug Eluting Devices Tier 1, Tier 2, and Tier 3
5 Contraceptive Drug Eluting Devices Market by Type
  1. 5.1 Global Contraceptive Drug Eluting Devices Revenue by Type
  2. 5.1.1 Global Contraceptive Drug Eluting Devices Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Contraceptive Drug Eluting Devices Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Contraceptive Drug Eluting Devices Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Contraceptive Drug Eluting Devices Sales by Type
  6. 5.2.1 Global Contraceptive Drug Eluting Devices Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Contraceptive Drug Eluting Devices Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Contraceptive Drug Eluting Devices Sales Market Share by Type (2021-2032)
  9. 5.3 Global Contraceptive Drug Eluting Devices Price by Type
6 Contraceptive Drug Eluting Devices Market by Application
  1. 6.1 Global Contraceptive Drug Eluting Devices Revenue by Application
  2. 6.1.1 Global Contraceptive Drug Eluting Devices Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Contraceptive Drug Eluting Devices Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Contraceptive Drug Eluting Devices Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Contraceptive Drug Eluting Devices Sales by Application
  6. 6.2.1 Global Contraceptive Drug Eluting Devices Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Contraceptive Drug Eluting Devices Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Contraceptive Drug Eluting Devices Sales Market Share by Application (2021-2032)
  9. 6.3 Global Contraceptive Drug Eluting Devices Price by Application
7 Company Profiles
  1. 7.1 CooperSurgical
  2. 7.1.1 CooperSurgical Company Information
  3. 7.1.2 CooperSurgical Business Overview
  4. 7.1.3 CooperSurgical Contraceptive Drug Eluting Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 CooperSurgical Contraceptive Drug Eluting Devices Product Portfolio
  6. 7.1.5 CooperSurgical Recent Developments
  7. 7.2 Egemen International
  8. 7.2.1 Egemen International Company Information
  9. 7.2.2 Egemen International Business Overview
  10. 7.2.3 Egemen International Contraceptive Drug Eluting Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Egemen International Contraceptive Drug Eluting Devices Product Portfolio
  12. 7.2.5 Egemen International Recent Developments
  13. 7.3 ERENLER MEDIKAL
  14. 7.3.1 ERENLER MEDIKAL Company Information
  15. 7.3.2 ERENLER MEDIKAL Business Overview
  16. 7.3.3 ERENLER MEDIKAL Contraceptive Drug Eluting Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 ERENLER MEDIKAL Contraceptive Drug Eluting Devices Product Portfolio
  18. 7.3.5 ERENLER MEDIKAL Recent Developments
  19. 7.4 Gyneas
  20. 7.4.1 Gyneas Company Information
  21. 7.4.2 Gyneas Business Overview
  22. 7.4.3 Gyneas Contraceptive Drug Eluting Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Gyneas Contraceptive Drug Eluting Devices Product Portfolio
  24. 7.4.5 Gyneas Recent Developments
  25. 7.5 Laboratoire CCD
  26. 7.5.1 Laboratoire CCD Company Information
  27. 7.5.2 Laboratoire CCD Business Overview
  28. 7.5.3 Laboratoire CCD Contraceptive Drug Eluting Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Laboratoire CCD Contraceptive Drug Eluting Devices Product Portfolio
  30. 7.5.5 Laboratoire CCD Recent Developments
  31. 7.6 Medical Engineering Corporation
  32. 7.6.1 Medical Engineering Corporation Company Information
  33. 7.6.2 Medical Engineering Corporation Business Overview
  34. 7.6.3 Medical Engineering Corporation Contraceptive Drug Eluting Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Medical Engineering Corporation Contraceptive Drug Eluting Devices Product Portfolio
  36. 7.6.5 Medical Engineering Corporation Recent Developments
  37. 7.7 Melbea
  38. 7.7.1 Melbea Company Information
  39. 7.7.2 Melbea Business Overview
  40. 7.7.3 Melbea Contraceptive Drug Eluting Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Melbea Contraceptive Drug Eluting Devices Product Portfolio
  42. 7.7.5 Melbea Recent Developments
  43. 7.8 Meril Life Sciences
  44. 7.8.1 Meril Life Sciences Company Information
  45. 7.8.2 Meril Life Sciences Business Overview
  46. 7.8.3 Meril Life Sciences Contraceptive Drug Eluting Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Meril Life Sciences Contraceptive Drug Eluting Devices Product Portfolio
  48. 7.8.5 Meril Life Sciences Recent Developments
  49. 7.9 Mona Lisa
  50. 7.9.1 Mona Lisa Company Information
  51. 7.9.2 Mona Lisa Business Overview
  52. 7.9.3 Mona Lisa Contraceptive Drug Eluting Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Mona Lisa Contraceptive Drug Eluting Devices Product Portfolio
  54. 7.9.5 Mona Lisa Recent Developments
  55. 7.10 Pregna
  56. 7.10.1 Pregna Company Information
  57. 7.10.2 Pregna Business Overview
  58. 7.10.3 Pregna Contraceptive Drug Eluting Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Pregna Contraceptive Drug Eluting Devices Product Portfolio
  60. 7.10.5 Pregna Recent Developments
  61. 7.11 Pregna International
  62. 7.11.1 Pregna International Company Information
  63. 7.11.2 Pregna International Business Overview
  64. 7.11.3 Pregna International Contraceptive Drug Eluting Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Pregna International Contraceptive Drug Eluting Devices Product Portfolio
  66. 7.11.5 Pregna International Recent Developments
  67. 7.12 Prosan International
  68. 7.12.1 Prosan International Company Information
  69. 7.12.2 Prosan International Business Overview
  70. 7.12.3 Prosan International Contraceptive Drug Eluting Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Prosan International Contraceptive Drug Eluting Devices Product Portfolio
  72. 7.12.5 Prosan International Recent Developments
  73. 7.13 Rongbo Medical
  74. 7.13.1 Rongbo Medical Company Information
  75. 7.13.2 Rongbo Medical Business Overview
  76. 7.13.3 Rongbo Medical Contraceptive Drug Eluting Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Rongbo Medical Contraceptive Drug Eluting Devices Product Portfolio
  78. 7.13.5 Rongbo Medical Recent Developments
  79. 7.14 SMB Corporation of India
  80. 7.14.1 SMB Corporation of India Company Information
  81. 7.14.2 SMB Corporation of India Business Overview
  82. 7.14.3 SMB Corporation of India Contraceptive Drug Eluting Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 SMB Corporation of India Contraceptive Drug Eluting Devices Product Portfolio
  84. 7.14.5 SMB Corporation of India Recent Developments
  85. 7.15 AbbVie
  86. 7.15.1 AbbVie Company Information
  87. 7.15.2 AbbVie Business Overview
  88. 7.15.3 AbbVie Contraceptive Drug Eluting Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 AbbVie Contraceptive Drug Eluting Devices Product Portfolio
  90. 7.15.5 AbbVie Recent Developments
  91. 7.16 Bayer
  92. 7.16.1 Bayer Company Information
  93. 7.16.2 Bayer Business Overview
  94. 7.16.3 Bayer Contraceptive Drug Eluting Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Bayer Contraceptive Drug Eluting Devices Product Portfolio
  96. 7.16.5 Bayer Recent Developments
8 North America
  1. 8.1 North America Contraceptive Drug Eluting Devices Market Size by Type
  2. 8.1.1 North America Contraceptive Drug Eluting Devices Revenue by Type (2021-2032)
  3. 8.1.2 North America Contraceptive Drug Eluting Devices Sales by Type (2021-2032)
  4. 8.1.3 North America Contraceptive Drug Eluting Devices Price by Type (2021-2032)
  5. 8.2 North America Contraceptive Drug Eluting Devices Market Size by Application
  6. 8.2.1 North America Contraceptive Drug Eluting Devices Revenue by Application (2021-2032)
  7. 8.2.2 North America Contraceptive Drug Eluting Devices Sales by Application (2021-2032)
  8. 8.2.3 North America Contraceptive Drug Eluting Devices Price by Application (2021-2032)
  9. 8.3 North America Contraceptive Drug Eluting Devices Market Size by Country
  10. 8.3.1 North America Contraceptive Drug Eluting Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Contraceptive Drug Eluting Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Contraceptive Drug Eluting Devices Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Contraceptive Drug Eluting Devices Market Size by Type
  2. 9.1.1 Europe Contraceptive Drug Eluting Devices Revenue by Type (2021-2032)
  3. 9.1.2 Europe Contraceptive Drug Eluting Devices Sales by Type (2021-2032)
  4. 9.1.3 Europe Contraceptive Drug Eluting Devices Price by Type (2021-2032)
  5. 9.2 Europe Contraceptive Drug Eluting Devices Market Size by Application
  6. 9.2.1 Europe Contraceptive Drug Eluting Devices Revenue by Application (2021-2032)
  7. 9.2.2 Europe Contraceptive Drug Eluting Devices Sales by Application (2021-2032)
  8. 9.2.3 Europe Contraceptive Drug Eluting Devices Price by Application (2021-2032)
  9. 9.3 Europe Contraceptive Drug Eluting Devices Market Size by Country
  10. 9.3.1 Europe Contraceptive Drug Eluting Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Contraceptive Drug Eluting Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Contraceptive Drug Eluting Devices Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Contraceptive Drug Eluting Devices Market Size by Type
  2. 10.1.1 China Contraceptive Drug Eluting Devices Revenue by Type (2021-2032)
  3. 10.1.2 China Contraceptive Drug Eluting Devices Sales by Type (2021-2032)
  4. 10.1.3 China Contraceptive Drug Eluting Devices Price by Type (2021-2032)
  5. 10.2 China Contraceptive Drug Eluting Devices Market Size by Application
  6. 10.2.1 China Contraceptive Drug Eluting Devices Revenue by Application (2021-2032)
  7. 10.2.2 China Contraceptive Drug Eluting Devices Sales by Application (2021-2032)
  8. 10.2.3 China Contraceptive Drug Eluting Devices Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Contraceptive Drug Eluting Devices Market Size by Type
  2. 11.1.1 Asia Contraceptive Drug Eluting Devices Revenue by Type (2021-2032)
  3. 11.1.2 Asia Contraceptive Drug Eluting Devices Sales by Type (2021-2032)
  4. 11.1.3 Asia Contraceptive Drug Eluting Devices Price by Type (2021-2032)
  5. 11.2 Asia Contraceptive Drug Eluting Devices Market Size by Application
  6. 11.2.1 Asia Contraceptive Drug Eluting Devices Revenue by Application (2021-2032)
  7. 11.2.2 Asia Contraceptive Drug Eluting Devices Sales by Application (2021-2032)
  8. 11.2.3 Asia Contraceptive Drug Eluting Devices Price by Application (2021-2032)
  9. 11.3 Asia Contraceptive Drug Eluting Devices Market Size by Country
  10. 11.3.1 Asia Contraceptive Drug Eluting Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Contraceptive Drug Eluting Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Contraceptive Drug Eluting Devices Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Contraceptive Drug Eluting Devices Market Size by Type
  2. 12.1.1 SAMEA Contraceptive Drug Eluting Devices Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Contraceptive Drug Eluting Devices Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Contraceptive Drug Eluting Devices Price by Type (2021-2032)
  5. 12.2 SAMEA Contraceptive Drug Eluting Devices Market Size by Application
  6. 12.2.1 SAMEA Contraceptive Drug Eluting Devices Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Contraceptive Drug Eluting Devices Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Contraceptive Drug Eluting Devices Price by Application (2021-2032)
  9. 12.3 SAMEA Contraceptive Drug Eluting Devices Market Size by Country
  10. 12.3.1 SAMEA Contraceptive Drug Eluting Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Contraceptive Drug Eluting Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Contraceptive Drug Eluting Devices Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Contraceptive Drug Eluting Devices Value Chain Analysis
  2. 13.1.1 Contraceptive Drug Eluting Devices Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Contraceptive Drug Eluting Devices Production Mode & Process
  6. 13.2 Contraceptive Drug Eluting Devices Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Contraceptive Drug Eluting Devices Distributors
  9. 13.2.3 Contraceptive Drug Eluting Devices Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst